Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms

liangli wang(Shenyang Pharmaceutical University), Chunfu Wu(Shenyang Pharmaceutical University)
Cell Death and Disease
January 21, 2016
Cited by 97


Related Papers